XTL BIOPHARMACEUTICALS LTD. Key Management Personnel Compensation Postemployment Benefits
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Key Management Personnel Compensation Postemployment Benefits of $341.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits · last filed 2025-04-30
| Period end | Key Management Personnel Compensation Postemployment Benefits 6 month | Key Management Personnel Compensation Postemployment Benefits 12 month |
|---|---|---|
| 2024-12-31 | $341.00K 20-F · filed 2025-04-30 | |
| 2023-12-31 | $240.00K 20-F · filed 2025-04-30 | |
| 2022-12-31 | $262.00K 20-F · filed 2025-04-30 | |
| 2020-12-31 | $2.00K 20-F · filed 2023-03-22 | |
| 2020-06-30 | $2.00K 6-K · filed 2021-08-24 | |
| 2019-12-31 | $7.00K 20-F · filed 2022-03-30 | |
| 2018-12-31 | $7.00K 20-F/A · filed 2021-05-19 | |
| 2017-12-31 | $12.00K 20-F · filed 2020-03-12 | |
| 2016-12-31 | $17.00K 20-F · filed 2019-03-11 | |
| 2015-12-31 | $16.00K 20-F · filed 2018-03-15 |